Press Release Contact

Press release:
SFA THERAPEUTICS, INC. ANNOUNCES START OF PHASE 1b CLINICAL TRIAL IN THE TREATMENT OF MILD-to-MODERATE PLAQUE PSORIASIS
April 08, 2021, 10:00 GMT

For questions about this press release, please contact the person or organization listed below.

Ira Spector
SFA Therapeutics, Inc.
+1 267-584-1080
Visit us on social media:
LinkedIn